Health Condition 1: null- Patients having Pregnancy associated breast cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with histological confirmed breast cancer who are pregnant Or Patients who got diagnosed within 1 year of last pregnancy with histological confirmed breast cancer Informed consent for data collection (for prospective participants only) For retrospective participants an informed consent is not required as long as the data are anonymously captured
Exclusion criteria
Exclusion criteria: Unwilling to participate Not able to give valid informed consent In retrospective registry where records not available
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stage and biological characteristics of breast cancer Breast cancer therapy Sensitivity and specificity of diagnostic procedures palpation USG mammogram Adverse events/side effects in PABC patients receiving chemotherapy compared to non-pregnant young women receiving chemotherapy Outcome of the newborn after therapy Outcome of breast cancer after diagnosis Rate of pregnancies after breast cancer Timepoint: Observational Trial,data will be assessed post completion of target accrual. | — |
Secondary
| Measure | Time frame |
|---|---|
| Observational Trial, for assessing on epidemiology and treatment patterns and outcomes of PABCTimepoint: Data will be assessed post completion of target accrual.;Stage and biological characteristics of breast cancer Breast cancer therapy Sensitivity and specificity of diagnostic procedures palpation USG mammogram Adverse events/side effects in PABC patients receiving chemotherapy compared to non-pregnant young women receiving chemotherapy Outcome of the newborn after therapy Outcome of breast cancer after diagnosis Rate of pregnancies after breast cancer Timepoint: Not applicable as its observational study both prospective and retroprospective | — |
Countries
India
Contacts
Tata Memorial Hospital